We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIR
RNS Number : 2596I
Circassia Pharmaceuticals Plc
15 June 2017
For filings with the FCA Email: majorshareholdings@fca.org.uk include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Circassia Pharmaceuticals the underlying issuer Plc of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ---------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ ------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ ------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ ------------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------ ------------------------------------- Other (please specify): --------------------------------------------------------- ------- ------------------------------------- 3. Full name of person(s) Neptune Investment Management subject to the Limited notification obligation: (iii) ----------------------------------------------------------- -------------------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.):(iv) ----------------------------------------------------------- -------------------------------------------- 5. Date of the transaction 14/06/17 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------------------------- 6. Date on which issuer 15/06/17 notified: ----------------------------------------------------------- -------------------------------------------- 7. Threshold(s) that is/are Exceeding 5% crossed or reached: (vi, vii) ----------------------------------------------------------- -------------------------------------------- 8. Notified details: --------------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) --------------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- ----------------------------- ------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ------------ ------------- ------------- --------- ------------ ----------- GB00BJVD3B28 16,603,412 16,603,412 16,649,900 16,649,900 N/A 5.01% N/A ------------- --------------- ----------------------------- ------------- ------------- --------- ------------ ----------- B: Qualifying Financial Instruments --------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- --------------- ------------------------------------------ -------------------------- --------------------- n/a n/a n/a n/a n/a ----------------- --------------- ------------------------------------------ -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) --------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- --------------- ------------- --------------------------- -------------------------- ----------------------- n/a n/a n/a n/a Nominal Delta --------------- --------------- ------------- --------------------------- ------------ --------- n/a n/a n/a ------------- ----------- ----------- ------------ ----------- -------------------------- ------------ --------- Total (A+B+C) --------------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------------------- ---------------------------------------------------------------- 16,649,900 5.01% --------------------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------- n/a Proxy Voting: ---------------------------------------------------------------------- 10. Name of the proxy holder: n/a ------------------------------------------------------- ------------- 11. Number of voting rights proxy n/a holder will cease to hold: ------------------------------------------------------- ------------- 12. Date on which proxy holder will n/a cease to hold voting rights: ------------------------------------------------------- ------------- 13. Additional information: n/a ------------------------------------------------------- ------------- 14. Contact name: Julien Cotta ------------------------------------------------------- ------------- 15. Contact telephone number: 01865 405560 ------------------------------------------------------- -------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFAMFTMBJBBFR
(END) Dow Jones Newswires
June 15, 2017 12:40 ET (16:40 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions